| Dr Mark K Milligan, MD | |
|
2075 N 1200 W, Layton, UT 84041-1616 | |
| (801) 779-6200 | |
| Not Available |
| Full Name | Dr Mark K Milligan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 2075 N 1200 W, Layton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194833244 | NPI | - | NPPES |
| 942854058645 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 932633921205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Layton Hospital | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Scientists generally think that reduced insulin production by the pancreas, a hallmark of type 2 diabetes, is due to the death of the organ's beta cells. However, a new study by Columbia University Medical Center (CUMC) researchers shows that beta cells do not die but instead revert to a more fundamental, undifferentiated cell type.
At Analytica 2016, the trade show for the laboratory field taking place in Munich from May 10th to 13th, KNAUER will be introducing a newly developed refractive index (RI) detector with most up-to-date features.
Medtronic, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved the use of INFUSE® Bone Graft in the treatment of acute, open fractures of the tibial shaft, a long bone in the lower leg. The approval broadens the indications for INFUSE Bone Graft, a product that has been used since 2002 in spinal surgery with metallic cages to treat tens of thousands of patients.
Television programs featuring healthy foods can be a key ingredient in leading children to make healthier food choices now and into adulthood.
At a time of alarming increases in obesity and associated diseases - and fiery debates about the cost of health care - a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Scientists generally think that reduced insulin production by the pancreas, a hallmark of type 2 diabetes, is due to the death of the organ's beta cells. However, a new study by Columbia University Medical Center (CUMC) researchers shows that beta cells do not die but instead revert to a more fundamental, undifferentiated cell type.
At Analytica 2016, the trade show for the laboratory field taking place in Munich from May 10th to 13th, KNAUER will be introducing a newly developed refractive index (RI) detector with most up-to-date features.
Medtronic, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved the use of INFUSE® Bone Graft in the treatment of acute, open fractures of the tibial shaft, a long bone in the lower leg. The approval broadens the indications for INFUSE Bone Graft, a product that has been used since 2002 in spinal surgery with metallic cages to treat tens of thousands of patients.
Television programs featuring healthy foods can be a key ingredient in leading children to make healthier food choices now and into adulthood.
At a time of alarming increases in obesity and associated diseases - and fiery debates about the cost of health care - a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Scientists generally think that reduced insulin production by the pancreas, a hallmark of type 2 diabetes, is due to the death of the organ's beta cells. However, a new study by Columbia University Medical Center (CUMC) researchers shows that beta cells do not die but instead revert to a more fundamental, undifferentiated cell type.
At Analytica 2016, the trade show for the laboratory field taking place in Munich from May 10th to 13th, KNAUER will be introducing a newly developed refractive index (RI) detector with most up-to-date features.
Medtronic, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved the use of INFUSE® Bone Graft in the treatment of acute, open fractures of the tibial shaft, a long bone in the lower leg. The approval broadens the indications for INFUSE Bone Graft, a product that has been used since 2002 in spinal surgery with metallic cages to treat tens of thousands of patients.
Television programs featuring healthy foods can be a key ingredient in leading children to make healthier food choices now and into adulthood.
At a time of alarming increases in obesity and associated diseases - and fiery debates about the cost of health care - a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark K Milligan, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 779-6200 | Dr Mark K Milligan, MD 2075 N 1200 W, Layton, UT 84041-1616 Ph: (801) 779-6200 |
News Archive
Scientists generally think that reduced insulin production by the pancreas, a hallmark of type 2 diabetes, is due to the death of the organ's beta cells. However, a new study by Columbia University Medical Center (CUMC) researchers shows that beta cells do not die but instead revert to a more fundamental, undifferentiated cell type.
At Analytica 2016, the trade show for the laboratory field taking place in Munich from May 10th to 13th, KNAUER will be introducing a newly developed refractive index (RI) detector with most up-to-date features.
Medtronic, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved the use of INFUSE® Bone Graft in the treatment of acute, open fractures of the tibial shaft, a long bone in the lower leg. The approval broadens the indications for INFUSE Bone Graft, a product that has been used since 2002 in spinal surgery with metallic cages to treat tens of thousands of patients.
Television programs featuring healthy foods can be a key ingredient in leading children to make healthier food choices now and into adulthood.
At a time of alarming increases in obesity and associated diseases - and fiery debates about the cost of health care - a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.
› Verified 8 days ago
Dr. Douglas Paul Barney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2132 North 1700 West, Suite 100, Layton, UT 84041 Phone: 801-807-7900 Fax: 801-807-7904 | |
Michael Dayton Delange, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3225 W Gordon Ave Ste 1, Layton, UT 84041 Phone: 801-397-6150 Fax: 801-397-6151 | |
Dr. Casey Lawrence Stelter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2940 N Church St, Layton, UT 84040 Phone: 801-475-3010 Fax: 801-475-3001 | |
Dr. Johnnie V Cook, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2075 N 1200 W, Layton, UT 84041 Phone: 801-779-6200 | |
Marc O Anderson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 No 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Ted H Burningham, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8187 |